High-dose, short-term folate may cut blood pressure

By Stephen Daniells

- Last updated on GMT

A short-term, high-dose supplementation period with folate may reduce blood pressure, and improve other cardiovascular measures, suggests a small study from Italy.

Fifteen post-menopausal women received a daily dose of 15 mg of 5-methyltetrahydrofolate, the naturally circulating form of folate, for three weeks, and experienced an average drop in systolic and diastolic blood pressure of 4.5 and 5.3 mmHg, respectively.

The results of the placebo-controlled study are published in the European Journal of Clinical Nutrition​.

“Whether maintained in the long term, 5-MTHF's cardiovascular and metabolic effect may contribute to primary cardiovascular prevention of postmenopausal women,” ​wrote the researchers from the Department of Obstetrics, Gynaecology and Paediatrics, Obstetrics and Gynaecology, at the Polyclinic of Modena.

The Italian researchers also reported a decrease in levels of homocysteine of 11.8 micromoles per litre for the folate group, compared to 8.7 micromoles per litre in the placebo group.

Studies have linked increased blood levels of the amino acid homocysteine to an increased risk of cardiovascular disease (CVD). It has been suggested that by lowering levels of homocysteine in the blood, people could cut the risk of cardiovascular disease. However, the topic of homocysteine and CVD is somewhat controversial with some studies reporting reductions in levels of the amino acid, but no reductions in the incidence of CVD over time.

Study details

The Modena-based scientists recruited 30 healthy post-menopausal women and randomly assigned them to one of two groups. The first received the daily 5-methyltetrahydrofolate dose of 15 mg, while the other group received a placebo.

While the placebo was not found to modify any of the parameters, the women in the folate group experienced drops in their nocturnal systolic and diastolic blood pressure levels, “in a way that was significantly different from that observed during placebo”​, said the researchers.

The high-dose folate supplement group also experienced significant reductions in homocysteine levels and in insulin resistance, whereby normal insulin amounts are inadequate to produce a normal insulin response from fat, muscle and liver cells.

Being a small, short-term study, the results need replication in larger, longer-term studies.

Folate is found in foods such as green leafy vegetables, chick peas and lentils. Folic acid - the synthetic, bioavailable form of folate – is obtained from grain products in the US and Canada following introduction of mandatory fortification in 1998.

Source: European Journal of Clinical Nutrition
Published online ahead of print, doi: 10.1038/ejcn.2009.58
"High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study"
Authors: A. Cagnacci, M. Cannoletta, A. Volp

Related news

Related products

show more

Active Ingredients for Women’s Health

Active Ingredients for Women’s Health

Content provided by Verdure Sciences | 08-Nov-2024 | White Paper

In the dynamic landscape of health, wellness, and nutrition, women’s health has been considered a niche market.

Brand Owners – Are You Getting the Supplement You Want?

Brand Owners – Are You Getting the Supplement You Want?

Content provided by Gemini Pharmaceuticals, Inc | 01-Nov-2024 | White Paper

Often the balance of “best value” and “best price” walks Brand Owners into a maze, and no industry seems to exemplify that like dietary supplements! However,...

Your Product Innovation Begins Here: Booth 4055

Your Product Innovation Begins Here: Booth 4055

Content provided by Effepharm Ltd | 22-Oct-2024 | Product Brochure

EffePharm will showcase innovative anti-aging solutions, featuring UthPeak™, world’s first self-GRAS approved NMNH, which boosts NAD+ levels by 10X. UthPeak™...

Related suppliers

Follow us

Products

View more

Webinars